<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Braun S</submitter><funding>Barncancerfonden (Swedish Childhood Cancer Foundation)</funding><funding>Vetenskapsrådet</funding><funding>Mats Paulsson foundations, Cancera foundation</funding><funding>Fru Berta Kamprads Stiftelse</funding><funding>Cancerfonden (Swedish Cancer Society)</funding><funding>Vetenskapsrådet (Swedish Research Council)</funding><funding>Region Skåne</funding><funding>Fru Berta Kamprads Stiftelse (Mrs. Berta Kamprad Foundation)</funding><funding>Barncancerfonden</funding><funding>Familjen Erling-Perssons Stiftelse</funding><funding>Knut och Alice Wallenbergs Stiftelse</funding><funding>Cancerfonden</funding><pagination>10918</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12680652</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>Glioblastoma (GBM) is characterized by fast progression, infiltrative growth pattern, and a high relapse rate. A defining feature of GBM is the existence of spatially and functionally distinct cellular niches, where malignant cells engage in paracrine crosstalk with cell types comprising the tumor microenvironment. Here, we identify pericytes as the most active paracrine signaling hub within the tumor parenchyma. Their depletion through genetic engineering results in accelerated tumor progression and shortened survival. Mechanistic studies reveal that pericyte deficiency remodels the endothelium and impacts the immune cell landscape, exacerbating tumor cell invasion and immune suppression. Specifically, the pericyte-deprived endothelium recruits perivascular, tumor-associated macrophages p</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma.</pubmed_title><pmcid>PMC12680652</pmcid><funding_grant_id>L2CancerBridge</funding_grant_id><funding_grant_id>PR2024-0121</funding_grant_id><funding_grant_id>2023-03136</funding_grant_id><funding_grant_id>24 3812 Pj</funding_grant_id><pubmed_authors>Harbst K</pubmed_authors><pubmed_authors>Pietras A</pubmed_authors><pubmed_authors>Braun S</pubmed_authors><pubmed_authors>Bolivar P</pubmed_authors><pubmed_authors>Sjolund J</pubmed_authors><pubmed_authors>Bocci M</pubmed_authors><pubmed_authors>Cordero E</pubmed_authors><pubmed_authors>Johansson E</pubmed_authors><pubmed_authors>Jonsson GB</pubmed_authors><pubmed_authors>Talkhoncheh MS</pubmed_authors><pubmed_authors>Phung B</pubmed_authors><pubmed_authors>Rosberg R</pubmed_authors><pubmed_authors>Oudenaarden C</pubmed_authors><pubmed_authors>Pietras K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma.</name><description>Glioblastoma (GBM) is characterized by fast progression, infiltrative growth pattern, and a high relapse rate. A defining feature of GBM is the existence of spatially and functionally distinct cellular niches, where malignant cells engage in paracrine crosstalk with cell types comprising the tumor microenvironment. Here, we identify pericytes as the most active paracrine signaling hub within the tumor parenchyma. Their depletion through genetic engineering results in accelerated tumor progression and shortened survival. Mechanistic studies reveal that pericyte deficiency remodels the endothelium and impacts the immune cell landscape, exacerbating tumor cell invasion and immune suppression. Specifically, the pericyte-deprived endothelium recruits perivascular, tumor-associated macrophages p</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-07-15T14:33:36.933Z</modification><creation>2026-07-06T03:08:38.761Z</creation></dates><accession>S-EPMC12680652</accession><cross_references><pubmed>41339360</pubmed><doi>10.1038/s41467-025-66985-1</doi></cross_references></HashMap>